Customise Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorised as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyse the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customised advertisements based on the pages you visited previously and to analyse the effectiveness of the ad campaigns.

No cookies to display.

Skip to Content
Upcoming Webinar

International Monthly Webinar – April 2025

Date: April 17, 2025 | 2:00 PM

Join us for our April International Monthly Webinar, featuring presentations on managing cytopenic myelofibrosis, CLL treatment trends, and strategic updates from NCODA leaders. 

Presentations include:

NCODA Regional Leader Opening Remarks – Region 17 (TX)
Tonya Robinson, RN, BSN, AM-BC | MD Anderson Cancer Center


NCODA Progressing with Passion – Exciting Organization Updates

Katie Edmiston | NCODA

Learn about the latest updates and progress at NCODA as we continue our efforts to drive innovation and enhance patient care.


Pacritinib in Cytopenic Myelofibrosis

Nicole Bentivegna, PharmD, BCOP | Florida Cancer Specialists & Research Institute
Vonda McClendon, CPhT | Texas Oncology Pharmacy Services

Explore strategies for transitioning patients with cytopenic myelofibrosis to pacritinib, including dosing considerations, managing hematologic adverse events through appropriate lab monitoring, and the role of proactive patient education in supporting adherence, minimizing complications, and improving outcomes.


CLL Treatment Trends & Takeaways: A Dive into the Insights Report

Kirollos Hanna, PharmD, BCPS, BCOP, FACCC, FAPO | Minnesota Oncology

Discover a personalized approach to treating newly diagnosed CLL, highlighting the role of BTK inhibitors in high-risk patients, the impact of genetic profiling and patient preferences, and strategies for monitoring, care coordination, and cost-effective decision-making.